Načítá se...

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection

BACKGROUND: We have constructed and clinically evaluated a hypoallergenic vaccine for grass pollen allergy, BM32, which is based on fusion proteins consisting of peptides from the IgE binding sites of the major grass pollen allergens fused to preS (preS1 + preS2), a domain of the hepatitis B virus (...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EBioMedicine
Hlavní autoři: Cornelius, Carolin, Schöneweis, Katrin, Georgi, Fanny, Weber, Milena, Niederberger, Verena, Zieglmayer, Petra, Niespodziana, Katarzyna, Trauner, Michael, Hofer, Harald, Urban, Stephan, Valenta, Rudolf
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5049759/
https://ncbi.nlm.nih.gov/pubmed/27568223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.07.023
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!